# Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

> **NCT04045405** · PHASE1 · COMPLETED · sponsor: **Cardior Pharmaceuticals GmbH** · enrollment: 28 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** CDR132L

## Key facts

- **NCT ID:** NCT04045405
- **Lead sponsor:** Cardior Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-21
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-06-26
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04045405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04045405, "Clinical Study to Assess Safety, PK and PD Parameters of CDR132L". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04045405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*